115 related articles for article (PubMed ID: 8399636)
1. Evaluation of carnitine levels according to the peritoneal equilibration test in patients on continuous ambulatory peritoneal dialysis.
Chatzidimitriou C; Pliakogiannis T; Evangeliou A; Tsalkidou T; Böhles HJ; Kalaitzidis K
Perit Dial Int; 1993; 13 Suppl 2():S444-7. PubMed ID: 8399636
[TBL] [Abstract][Full Text] [Related]
2. Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal dialysis.
Pliakogiannis T; Chatzidimitriou C; Evangeliou A; Böhles HJ; Kalaitzidis K
Perit Dial Int; 1993; 13 Suppl 2():S440-3. PubMed ID: 8399635
[TBL] [Abstract][Full Text] [Related]
3. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis.
Wanner C; Förstner-Wanner S; Schaeffer G; Schollmeyer P; Hörl WH
Am J Nephrol; 1986; 6(3):206-11. PubMed ID: 3740128
[TBL] [Abstract][Full Text] [Related]
4. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
[TBL] [Abstract][Full Text] [Related]
5. Absolute and Relative Carnitine Deficiency in Patients on Hemodialysis and Peritoneal Dialysis.
Naseri M; Mottaghi Moghadam Shahri H; Horri M; Esmaeeli M; Ghaneh Sherbaf F; Jahanshahi S; Moeenolroayaa G; Rasoli Z; Salemian F; Pour Hasan M
Iran J Kidney Dis; 2016 Jan; 10(1):36-43. PubMed ID: 26837680
[TBL] [Abstract][Full Text] [Related]
6. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
7. Continuous ambulatory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level.
Grzegorzewska AE; Mariak I; Dobrowolska-Zachwieja A
Int Urol Nephrol; 1999; 31(4):533-40. PubMed ID: 10668949
[TBL] [Abstract][Full Text] [Related]
8. Serum carnitine and nutritional status in children treated with continuous ambulatory peritoneal dialysis.
Murakami R; Momota T; Yoshiya K; Yoshikawa N; Nakamura H; Honda M; Ito H
J Pediatr Gastroenterol Nutr; 1990 Oct; 11(3):371-4. PubMed ID: 2246721
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors.
Little J; Phillips L; Russell L; Griffiths A; Russell GI; Davies SJ
J Am Soc Nephrol; 1998 Oct; 9(10):1931-9. PubMed ID: 9773795
[TBL] [Abstract][Full Text] [Related]
10. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis.
Misra M; Reaveley DA; Ashworth J; Muller B; Seed M; Brown EA
Perit Dial Int; 1997; 17(3):279-86. PubMed ID: 9237290
[TBL] [Abstract][Full Text] [Related]
11. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG
Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232
[TBL] [Abstract][Full Text] [Related]
12. Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis.
Warady BA; Borum P; Stall C; Millspaugh J; Taggart E; Lum G
Am J Nephrol; 1990; 10(2):109-14. PubMed ID: 2349954
[TBL] [Abstract][Full Text] [Related]
13. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
[TBL] [Abstract][Full Text] [Related]
15. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
17. Potential role of carnitine in patients with renal insufficiency.
Wanner C; Hörl WH
Klin Wochenschr; 1986 Jul; 64(13):579-86. PubMed ID: 3091903
[TBL] [Abstract][Full Text] [Related]
18. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
Böhles H; Michalk D; von Wendt-Göknur E
Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
[TBL] [Abstract][Full Text] [Related]
19. Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients.
Constantin-Teodosiu D; Kirby DP; Short AH; Burden RP; Morgan AG; Greenhaff PL
Kidney Int; 1996 Jan; 49(1):158-62. PubMed ID: 8770962
[TBL] [Abstract][Full Text] [Related]
20. Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.
Gao H; Lew SQ; Bosch JP
Am J Nephrol; 1999; 19(1):7-12. PubMed ID: 10085443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
